Michael Joseph Tremblay - Net Worth and Insider Trading
Michael Joseph Tremblay Net Worth
The estimated net worth of Michael Joseph Tremblay is at least $10,340 dollars as of 2024-11-12. Michael Joseph Tremblay is the Director of Knight Therapeutics Inc and owns about 2,000 shares of Knight Therapeutics Inc (TSX:GUD) stock worth over $10,340. Details can be seen in Michael Joseph Tremblay's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Joseph Tremblay has not made any transactions after 2021-05-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Joseph Tremblay
Michael Joseph Tremblay Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Joseph Tremblay owns 1 companies in total, including Knight Therapeutics Inc (TSX:GUD) .
Click here to see the complete history of Michael Joseph Tremblay’s form 4 insider trades.
Insider Ownership Summary of Michael Joseph Tremblay
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2021-05-27 | Director |
Michael Joseph Tremblay Latest Holdings Summary
Michael Joseph Tremblay currently owns a total of 1 stock. Michael Joseph Tremblay owns 2,000 shares of Knight Therapeutics Inc (TSX:GUD) as of May 27, 2021, with a value of $10,340.
Latest Holdings of Michael Joseph Tremblay
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2021-05-27 | 2,000 | 5.17 | 10,340 |
Holding Weightings of Michael Joseph Tremblay
Michael Joseph Tremblay Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Joseph Tremblay has made a total of 1 transactions in Knight Therapeutics Inc (TSX:GUD) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Knight Therapeutics Inc is the acquisition of 2,000 shares on May 27, 2021, which cost Michael Joseph Tremblay around $10,430.
Insider Trading History of Michael Joseph Tremblay
- 1
Michael Joseph Tremblay Trading Performance
GuruFocus tracks the stock performance after each of Michael Joseph Tremblay's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Joseph Tremblay is 1.7%. GuruFocus also compares Michael Joseph Tremblay's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Joseph Tremblay within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Joseph Tremblay's insider trading performs compared to the benchmark.
Performance of Michael Joseph Tremblay
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.22 | | | | | |
| Relative Return to S&P 500(%) | 1.32 | | | | | |
Michael Joseph Tremblay Ownership Network
Ownership Network List of Michael Joseph Tremblay
Ownership Network Relation of Michael Joseph Tremblay
Michael Joseph Tremblay Owned Company Details
What does Knight Therapeutics Inc do?
Who are the key executives at Knight Therapeutics Inc?
Michael Joseph Tremblay is the Director of Knight Therapeutics Inc. Other key executives at Knight Therapeutics Inc include Director & Senior Officer Samira Sakhia , Senior Officer Amal Khouri , and Director & Director or Senior Officer of 10% Security Holder Jonathan Ross Goodman .
Knight Therapeutics Inc (TSX:GUD) Insider Trades Summary
Over the past 18 months, Michael Joseph Tremblay made no insider transaction in Knight Therapeutics Inc (TSX:GUD). Other recent insider transactions involving Knight Therapeutics Inc (TSX:GUD) include a net purchase of 674,800 shares made by Sime Armoyan , a net sale of 65,000 shares made by Amal Khouri , and a net sale of 45,000 shares made by Robert Nathaniel Lande .
In summary, during the past 3 months, insiders sold 20,100 shares of Knight Therapeutics Inc (TSX:GUD) in total and bought 20,000 shares, with a net sale of 100 shares. During the past 18 months, 314,200 shares of Knight Therapeutics Inc (TSX:GUD) were sold and 949,000 shares were bought by its insiders, resulting in a net purchase of 634,800 shares.
Knight Therapeutics Inc (TSX:GUD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Knight Therapeutics Inc Insider Transactions
Michael Joseph Tremblay Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Joseph Tremblay. Currently GuruFocus does not have mailing address information for Michael Joseph Tremblay.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
